COMPANY PROFILE

Q’Apel Medical

Explore full profile

Designing novel access device technology for neurovascular interventions and unmet clinical needs

Fremont, United StatesFounded 2016Health Tech & Medtech

Valuation $50–100M Last recorded · 2024

Headcount 100–500 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Q’Apel Medical

Q'Apel Medical specializes in developing advanced neurovascular access and aspiration systems designed to improve stroke care. The company serves neurovascular specialists and healthcare providers focused on treating stroke patients. Operating in the medical device market, Q'Apel Medical's business model revolves around the design, manufacture, and sale of specialized catheters and aspiration systems. Revenue is generated through the direct sale of these medical devices to hospitals and healthcare facilities. Key products include the CHEETAH aspiration system, which offers rapid and visible clot engagement, and the ARMADILLO neurovascular access system, known for its balance between trackability and support. The company emphasizes innovation and collaboration with medical professionals to create solutions that address specific and urgent needs in stroke care.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Fremont, United States
Employees: 115
Open positions: None listed
Dealroom signal: 75.4/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Surgery, Neurology, Catheters, Hard Tech, DT and LS, science-based, stroke
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	May 2024	$17M	$68M	Undisclosed	↗
LATE VCOther financing	Apr 2022	$30M	$120M	Undisclosed	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Q’Apel Medical website traffic

Latest recorded traffic for Q’Apel Medical is 2.1K monthly website visits, up 23.5% over the last three months. Q’Apel Medical's team declined 2.5% over the past year.

Latest monthly visits2.1K 3-month web change+23.5% 1-year team growth-2.5%

Monthly website visitsJan 2021–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Post-Market Surveillance Analyst/EngineerFremont, CA · Business Intelligence · Sep 5, 2026 Senior Human Resources GeneralistFremont, CA · Human Resources · Aug 26, 2026

2 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SCStroke CareFocusing on the development and industrialization of new minimally invasive interventional technologies for stroke prevention and treatment	Huangpu, China	Operational	14	$24M	$40M
MAMagnendoRobotic neurovascular access for stroke and aneurysm treatment	United States	Operational
LMLairui MedicalDeveloper and manufacturer of neurointerventional medical devices designed to provide solutions for ischemic and hemorrhagic stroke	China	Operational
RARapidPulsePrivately held medical device company that develops minimally invasive vascular products for ischemic stroke	Miami, United States	Operational
BTBendit TechnologiesDeveloping navigational microcatheters with 3D controlled steering that can be piloted in the body	Petah Tikva, Israel	Operational
INInNeuroCoFocuses on creating and delivering high-quality complex catheter solutions	Sunrise, United States	Operational
ZMZylox MedicalInterventional medical devices for neurovascular and peripheral diseases	Hangzhou, China	Operational
VEVesalioVesalio is a privately held medical device company focused on advancing technology needed to improve outcomes in stroke treatment	Nashville, United States	Operational